Inhibition of HSP90 can prolong HSF1 activity, resulting in enhanced heat shock responses, which could be used in cancer therapy (Kijima et al., 2019; Cyran and Zhitkovich, 2022). This evidence concerns the gene HSP90AA1 and cancer.